VEGF and tPA co-expressed in malignant glioma

Acta Oncol. 1997;36(6):615-8. doi: 10.3109/02841869709001324.

Abstract

Neovascularisation and migration of tumour cells are two features of highly malignant glioma. Vascular endothelial growth factor (VEGF) and tissue plasminogen activator (tPA) seem to be of importance in the process of malignancy. In the present study a topographical co-expression of tPA mRNA and VEGF mRNA (VEGF121 and VEGF165 isoforms) was demonstrated in the tumour edge of a rat malignant glioma, using in situ hybridisation. No signs of co-expression was seen in the normal brain tissue. In the normal brain the forms of VEGF mainly expressed were VEGF121, VEGF165, and VEGF189. Further studies are required to show whether VEGF and tPA are produced by the same tumour cells and to elucidate the role of this co-expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain Neoplasms / metabolism*
  • Cell Division / physiology
  • Disease Models, Animal
  • Endothelial Growth Factors / biosynthesis*
  • Glioma / metabolism*
  • In Situ Hybridization
  • Lymphokines / biosynthesis*
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Polymerase Chain Reaction
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred Strains
  • Tissue Plasminogen Activator / biosynthesis*
  • Transcription, Genetic
  • Tumor Cells, Cultured
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Lymphokines
  • RNA, Messenger
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Tissue Plasminogen Activator